Author

K. Tsujita

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Lipid management in patients with coronary artery disease at risk of a first major atherosclerotic cardiovascular event: findings from the VESALIUS-REAL global study

In this large, global, real-world study, most patients with CAD at risk of a first MACE were undertreated with LLT and did not achieve recommended LDL-C levels, highlighting substantial gaps between guideline recommendations and real-world practice.

Q. Chan, J. Cegla, J. Cornel et al. · European Heart Journal · 0 citations

Open access Oct 2026

Circulating angiopoietin-like protein 3 levels and subsequent cardiovascular outcomes in patients with coronary artery disease

An increased risk of cardiovascular events was observed in patients with CAD who exhibited ANGPTL3> 363.4 ng/mL, and the findings suggest circulating ANGPTL3 as a potential therapeutic target to further mitigate subsequent cardiovascular events’ risks in patients with CAD.

S. Fujita, Y. Kataoka, N. Kuyama et al. · European Heart Journal · 0 citations

Aug 2026

Prognostic utility of natriuretic peptides and incremental value of the HFA-ICOS risk score in patients with multiple myeloma

In patients with MM, baseline BNP levels demonstrated fair discrimination for predicting heart failure and all-cause mortality, and equivalent predictive performance compared with the HFA-ICOS risk score, which supports the use of BNP levels as an efficient tool for risk stratification in patients with MM.

N. Nakanishi, M. Akagi, M. Yamamoto et al. · European Heart Journal, Supp... · 0 citations